Abstract
This chapter summarizes the application of electroretinogram and/or electrooculogram in patients with Stargardt’s disease, fundus flavimaculatus, X-linked retinoschisis, vitelliform macular dystrophy (Best’s disease), pattern dystrophies, macular pattern dystrophy, Doyne’s honeycomb macular dystrophy, occult macular dystrophy, and North Carolina macular dystrophy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bax NM. The portal for rare diseases and orphan drugs. Orphanet: About Orphan Drugs. 2019. Available from: www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&Expert=827 http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&Expert=827.
Allikmets R, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science. 1997;277(5333):1805–7.
Michaelides M, Hunt DM, Moore AT. The genetics of inherited macular dystrophies. J Med Genet. 2003;40(9):641–50.
Boon CJ, et al. Mutations in the peripherin/RDS gene are an important cause of multifocal pattern dystrophy simulating STGD1/fundus flavimaculatus. Br J Ophthalmol. 2007;91(11):1504–11.
Cideciyan AV, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004;13(5):525–34.
Fishman GA, et al. Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch Ophthalmol. 1999;117(4):504–10.
Kuniyoshi K, et al. Multifocal electroretinograms in Stargardt’s disease/fundus flavimaculatus. Ophthalmologica. 2014;232(2):118–25.
Haas J. Ueber das zusammenvorkommen von Veranderungen der retina und choroidea. Arch Augenheilkd. 1898;37:343–8.
George ND, Yates JR, Moore AT. X linked retinoschisis. Br J Ophthalmol. 1995;79(7):697–702.
Wu WW, Molday RS. Defective discoidin domain structure, subunit assembly, and endoplasmic reticulum processing of retinoschisin are primary mechanisms responsible for X-linked retinoschisis. J Biol Chem. 2003;278(30):28139–46.
Sieving PA, Yashar BM, Ayyagari R. Juvenile retinoschisis: a model for molecular diagnostic testing of X-linked ophthalmic disease. Trans Am Ophthalmol Soc. 1999;97:451–64; discussion 464–9.
Cukras CA, et al. Analysis of anatomic and functional measures in X-linked retinoschisis. Invest Ophthalmol Vis Sci. 2018;59(7):2841–7.
Sieving PA, MacDonald IM, Chan S. X-linked juvenile retinoschisis. In: Adam MP, et al., editors. GeneReviews(R). University of Washington, Seattle; 2014.
Iannaccone A. Optical coherence tomography in rare pediatric cases. Retina Today. 2012(September). pp. 1–3.
Iannaccone A, et al. An unusual X-linked retinoschisis phenotype and biochemical characterization of the W112C RS1 mutation. Vision Res. 2006;46(22):3845–52.
Ghajarnia M, Gorin MB. Acetazolamide in the treatment of X-linked retinoschisis maculopathy. Arch Ophthalmol. 2007;125(4):571–3.
Miyake Y, et al. Focal macular electroretinogram in X-linked congenital retinoschisis. Invest Ophthalmol Vis Sci. 1993;34(3):512–5.
Kim LS, et al. Multifocal ERG findings in carriers of X-linked retinoschisis. Doc Ophthalmol. 2007;114(1):21–6.
Huang S, et al. The multifocal electroretinogram in X-linked juvenile retinoschisis. Doc Ophthalmol. 2003;106(3):251–5.
White K, Marquardt A, Weber BH. VMD2 mutations in vitelliform macular dystrophy (Best disease) and other maculopathies. Hum Mutat. 2000;15(4):301–8.
Marchant D, et al. New VMD2 gene mutations identified in patients affected by Best vitelliform macular dystrophy. J Med Genet. 2007;44(3):e70.
Boon CJ, et al. The spectrum of ocular phenotypes caused by mutations in the BEST1 gene. Prog Retin Eye Res. 2009;28(3):187–205.
Iannaccone A, et al. Autosomal recessive best vitelliform macular dystrophy: report of a family and management of early-onset neovascular complications. Arch Ophthalmol. 2011;129(2):211–7.
Burgess R, et al. Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet. 2008;82(1):19–31.
Boon CJ, et al. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options. Ophthalmology. 2013;120(4):809–20.
Davidson AE, et al. Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa. Am J Hum Genet. 2009;85(5):581–92.
Renner AB, et al. Late onset is common in best macular dystrophy associated with VMD2 gene mutations. Ophthalmology. 2005;112(4):586–92.
Kaufman SJ, et al. Autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol. 1982;100(2):272–8.
Blair NP, et al. Autosomal dominant vitreoretinochoroidopathy (ADVIRC). Br J Ophthalmol. 1984;68(1):2–9.
Goldberg MF, et al. Ocular histopathology and immunohistochemical analysis in the oldest known individual with autosomal dominant vitreoretinochoroidopathy. Ophthalmol Retina. 2018;2(4):360–78.
MacDonald IM, Lee T. Best vitelliform macular dystrophy. In: Pagon RA, et al., editors. GeneReviews(R). University of Washington, Seattle; 1993.
Glybina IV, Frank RN. Localization of multifocal electroretinogram abnormalities to the lesion site: findings in a family with Best disease. Arch Ophthalmol. 2006;124(11):1593–600.
Lafaut BA, et al. Clinical and electrophysiological findings in autosomal dominant vitreoretinochoroidopathy: report of a new pedigree. Graefes Arch Clin Exp Ophthalmol. 2001;239(8):575–82.
Zhang K, et al. Butterfly-shaped pattern dystrophy: a genetic, clinical, and histopathological report. Arch Ophthalmol. 2002;120(4):485–90.
Stone EM, et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet. 1999;22(2):199–202.
Haimovici R, et al. Symptomatic abnormalities of dark adaptation in patients with EFEMP1 retinal dystrophy (Malattia Leventinese/Doyne honeycomb retinal dystrophy). Eye (Lond). 2002;16(1):7–15.
Akahori M, et al. Dominant mutations in RP1L1 are responsible for occult macular dystrophy. Am J Hum Genet. 2010;87(3):424–9.
Miyake Y, Tsunoda K. Occult macular dystrophy. Jpn J Ophthalmol. 2015;59(2):71–80.
Hayashi T, et al. Autosomal dominant occult macular dystrophy with an RP1L1 mutation (R45W). Optom Vis Sci. 2012;89(5):684–91.
Kondo M, et al. Occult macular dystrophy in an 11 year old boy. Br J Ophthalmol. 2004;88(12):1602–3.
Piao CH, et al. Multifocal electroretinogram in occult macular dystrophy. Invest Ophthalmol Vis Sci. 2000;41(2):513–7.
Ahn SJ, et al. Multimodal imaging of occult macular dystrophy. JAMA Ophthalmol. 2013;131(7):880–90.
Tsunoda K, et al. Clinical characteristics of occult macular dystrophy in family with mutation of RP1l1 gene. Retina. 2012;32(6):1135–47.
Kondo M, Miyake Y. Assessment of local cone on- and off-pathway function using multifocal ERG technique. Doc Ophthalmol. 2000;100(2–3):139–54.
Kabuto T, et al. A new mutation in the RP1L1 gene in a patient with occult macular dystrophy associated with a depolarizing pattern of focal macular electroretinograms. Mol Vis. 2012;18:1031–9.
Small KW, et al. North Carolina macular dystrophy and central areolar pigment epithelial dystrophy. One family, one disease. Arch Ophthalmol. 1992;110(4):515–8.
Lefler WH, Wadsworth JA, Sidbury JB Jr. Hereditary macular degeneration and amino-aciduria. Am J Ophthalmol. 1971;71(1 Pt 2):224–30.
Small KW, et al. North Carolina macular dystrophy phenotype in France maps to the MCDR1 locus. Mol Vis. 1997;3:1.
Sauer CG, et al. An ancestral core haplotype defines the critical region harbouring the North Carolina macular dystrophy gene (MCDR1). J Med Genet. 1997;34(12):961–6.
Reichel MB, et al. Phenotype of a British North Carolina macular dystrophy family linked to chromosome 6q. Br J Ophthalmol. 1998;82(10):1162–8.
Yang Z, et al. Clinical characterization and genetic mapping of North Carolina macular dystrophy. Vision Res. 2008;48(3):470–7.
Khurana RN, et al. A reappraisal of the clinical spectrum of North Carolina macular dystrophy. Ophthalmology. 2009;116(10):1976–83.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kheir, W.J. et al. (2019). Macular Dystrophies. In: Yu, M., Creel, D., Iannaccone, A. (eds) Handbook of Clinical Electrophysiology of Vision. Springer, Cham. https://doi.org/10.1007/978-3-030-30417-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-30417-1_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-30416-4
Online ISBN: 978-3-030-30417-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)